Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. - Suppr | 超能文献

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

作者信息

Vaiani M, Trippoli S, Messori A

出版信息

N Engl J Med. 2001 Jan 25;344(4):305-6; author reply 306-7. doi: 10.1056/NEJM200101253440413.

DOI:10.1056/NEJM200101253440413

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

N Engl J Med. 2001 Jan 25;344(4):305-6; author reply 306-7. doi: 10.1056/NEJM200101253440413.

2

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

N Engl J Med. 2001 Jan 25;344(4):305; author reply 306-7.

3

Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.

Cancer. 2012 Jun 15;118(12):3173-81. doi: 10.1002/cncr.26613. Epub 2011 Oct 21.

4

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

N Engl J Med. 2001 Jan 25;344(4):306; author reply 306-7.

5

Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.

Jpn J Clin Oncol. 2007 Sep;37(9):686-91. doi: 10.1093/jjco/hym091. Epub 2007 Aug 24.

6

Cost-effectiveness of Capecitabine + Irinotecan Versus Leucovorin + Fluorouracil + Irinotecan in the Second-line Treatment of Metastatic Colorectal Cancer in China.

Clin Ther. 2020 Nov;42(11):2148-2158.e2. doi: 10.1016/j.clinthera.2020.08.015. Epub 2020 Sep 25.

7

Considering Efficacy and Cost, Where Does Ramucirumab Fit in the Management of Metastatic Colorectal Cancer?

Oncologist. 2015 Sep;20(9):981-2. doi: 10.1634/theoncologist.2015-0028. Epub 2015 Aug 11.

8

Cetuximab as First-line Treatment for Metastatic Colorectal Cancer: Caution With Interpretation of Cost-Effectiveness Results Toward Medical Decision Making.

Am J Clin Oncol. 2016 Apr;39(2):214. doi: 10.1097/COC.0000000000000253.

9

Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.

Clin Ther. 2011 Apr;33(4):482-97. doi: 10.1016/j.clinthera.2011.04.010.

10

Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.

N Engl J Med. 2001 Jul 12;345(2):145-6.

引用本文的文献

1

First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis.

J Clin Oncol. 2015 Apr 1;33(10):1112-8. doi: 10.1200/JCO.2014.58.4904. Epub 2015 Feb 17.